Control of cerebral vasospasm by parenteral phenoxybenzamine.
D000317:Adrenergic alpha-Antagonists / Q000627:therapeutic use; D000818:Animals; D001488:Basilar Artery / Q000187:drug effects*; D001794:Blood Pressure / Q000187:drug effects; D002415:Cats; D004562:Electrocardiography; D002546:Ischemic Attack, Transient / Q000188:drug therapy*; D009638:Norepinephrine / Q000627:therapeutic use; D010643:Phenoxybenzamine / Q000008:administration & dosage* / Q000627:therapeutic use; D010646:Phentolamine / Q000627:therapeutic use; D013345:Subarachnoid Hemorrhage / Q000188:drug therapy
D000317:Adrenergic alpha-Antagonists; D010643:Phenoxybenzamine; D009638:Norepinephrine; D010646:Phentolamine